Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News VolitionRX Ltd VNRX

Healthcare Medical Instruments & Supplies
VolitionRx Limited is a multi-national epigenetics company focused on advancing the science of epigenetics. The Company is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and... see more

Recent & Breaking News (NYSEAM:VNRX)

'Zooming with LD' to Feature 10 Distinct Companies July 20th-31st

Accesswire July 16, 2020

Volition Announces Promising Clinical Trials Results for its Novel COVID-19 Triage Test

PR Newswire July 14, 2020

Cotterford Co. Ltd. Sends Letter to VolitionRX Following Annual Meeting Vote Results Confirming Deep-Seated Discontent Among Shareholders

Business Wire July 9, 2020

VolitionRx Releases Business Update Video and Announces Addition to the Russell 3000® and Russell Microcap® Indexes

PR Newswire June 25, 2020

Cotterford Co. Ltd. Sends Letter to Board of VolitionRX

Business Wire June 10, 2020

Volition Announces Cameron Reynolds, President and Chief Executive Officer Invited as Presenter at Maxim's COVID-19 Virtual Conference

PR Newswire May 27, 2020

VolitionRx Announces Closing of $13.8 Million Public Offering of Common Stock

PR Newswire May 22, 2020

VolitionRx Announces Pricing of Underwritten Public Offering of Common Stock

PR Newswire May 20, 2020

VolitionRx Announces Proposed Underwritten Public Offering of Common Stock

PR Newswire May 19, 2020

VolitionRx To Present First Data on Nu.Q(TM) Capture Performance and Nu.Q(TM) Assay Performance in Lung Cancer and Blood Cancer at the 2020 ASCO Annual Meeting

PR Newswire May 13, 2020

VolitionRx Limited Announces First Quarter 2020 Financial Results and Business Update

PR Newswire May 7, 2020

VolitionRx Limited Schedules First Quarter 2020 Earnings Conference Call and Business Update

PR Newswire May 5, 2020

Volition's Nu.Q(TM) Vet Assay Detects Two Common Canine Cancers

PR Newswire April 29, 2020

Volition Files Patent for Nu.Q(TM) COVID-19 Triage Test and Commences Proof of Concept Studies

PR Newswire April 23, 2020

VolitionRx Limited Releases Annual Corporate Brochure and Video

PR Newswire March 10, 2020

VolitionRx Limited to Present at Conferences in March 2020

PR Newswire March 3, 2020

VolitionRx Limited Announces Full Fiscal Year 2019 Financial Results and Business Update

PR Newswire February 20, 2020

VolitionRx Limited Schedules Full Year 2019 Earnings Conference Call and Business Update

PR Newswire February 18, 2020

Volition Unveils Its Epigenetic Toolbox

PR Newswire February 18, 2020

VolitionRx Announces Filing of Registration Statements

PR Newswire February 7, 2020